Industry reports
Editor highlights

Publication dates

All regions

Breast Cancer Research Reports, April 2014

You might be interested in: cancer, prostate cancer, medical equipment, more »


 

1-20 of about 7 900 reports for Breast Cancer
Metastatic Breast Cancer Global Clinical Trials Review, H1, 2014

Metastatic Breast Cancer Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • March 2014
  • by Global Data

... To the clinical trials on metastatic breast cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary ...

Breast Cancer Drug Pathway Analyzer 2014

Breast Cancer Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

... Specifications3. Compare - you can overlay any pathways with each other and do a comparative analysisyou can interactively analyze any breast cancer drug-pathway relationship by using up to four ...

Analytical Tool - Breast Cancer

Analytical Tool - Breast Cancer

  • $ 4 650
  • Industry report
  • March 2014
  • by Bioseeker

... In the field of breast cancer drug development, in order to help you perform your own analysis, go back to the source data for in-depth information, and present the research and development in tables and graphs ...

Breast Cancer Drug Pipeline Update 2014

Breast Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

... In addition, there are 8 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 207 drugs. breast cancer drug pipeline update lists all drugs and gives you a progress ...

Dana-Farber Cancer Institute, Inc. - Medical Equipment - Deals and Alliances Profile

Dana-Farber Cancer Institute, Inc. - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2014
  • by Global Data

... Cancer and sarcoma. The company provides post-graduate training in hematology and oncology to the physicians. Its treatment centers include blood cancer, breast cancer, cancer genetics and prevention ...

Hormone Refractory Breast Cancer Global Clinical Trials Review, H1, 2014

Hormone Refractory Breast Cancer Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • March 2014
  • by Global Data

... Information and data relating to the clinical trials on hormone refractory breast cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across ...

Hormone Sensitive Breast Cancer Global Clinical Trials Review, H1, 2014

Hormone Sensitive Breast Cancer Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • March 2014
  • by Global Data

... Information and data relating to the clinical trials on hormone sensitive breast cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across ...

Breast Cancer Partnering 2009-2014

Breast Cancer Partnering 2009-2014

  • $ 1 795
  • Industry report
  • March 2014
  • by Currentpartnering

... Report contains over 250 links to online copies of actual breast cancer deals and contract documents as submitted to the securities exchange commission by companies and their partners, where available ...

2014 Deep Research Report on Global and China Breast Localization Wire Industry

2014 Deep Research Report on Global and China Breast Localization Wire Industry

  • $ 2 200
  • Industry report
  • March 2014
  • by QY Research Group

... Figure 2013 global major countries breast localization wire production market share 9figure 2014-2019 global breast localization wire capacity production and growth rate 10figure estimated breast cancer ...

World Drug and Medication: Endometrial Cancer – Pipeline Review, H1 2012

World Drug and Medication: Endometrial Cancer – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

... On lenvatinib at asco annual meeting 163may 15, 2013: arno therapeutics to present positive new data on onapristone in endometrial and breast cancers at asco 2013 annual meeting 164appendix 166 ...


» Read our Company Profiles

1 Companies for Breast Cancer

GlaxoSmithKline P.L.C.

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.